ALK+ ALCL is characterized by chromosomal translocations involving ALK at chromosome 2p23 and resultant ALK expression, representing approximately 10–15% of pediatric/adolescent and ~3% of adult non-Hodgkin lymphomas [1,2,3]. This evidence concerns the gene ALK and non-Hodgkin lymphoma.